CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), No. 11 Beiyitiao, Zhongguancun, Beijing 100190, China
Sino-Danish College, Sino-Danish Center for Education and Research, University of Chinese Academy of Sciences, Beijing 100049, China
School of Chemical Engineering and Technology, Hebei University of Technology, Tianjin 300130, China
Tianjin Medical University General Hospital, Tianjin 300052, China
University of Chinese Academy of Sciences, Beijing 100049, China
School of Environmental Science and Safety Engineering, Tianjin University of Technology, Tianjin 300384, China
College of Pharmacy, Chongqing Medical University, Chongqing 400016, China
School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China
§ Zhen Luo, Yuxing Jiang, Zimo Liu, and Lamei Guo contributed equally to this work.
Show Author Information
Hide Author Information
The online version of the original article can be found at:
Luo Z, Jiang Y, Liu Z, et al. Erratum to: Selenopeptide nanomedicine ameliorates atherosclerosis by reducing monocyte adhesions and inflammations. Nano Research, 2025, 18(4): 94907396. https://doi.org/10.26599/NR.2025.94907396